Published in Pain Manag on November 01, 2013
The Total Neuropathy Score as an assessment tool for grading the course of chemotherapy-induced peripheral neurotoxicity: comparison with the National Cancer Institute-Common Toxicity Scale. J Peripher Nerv Syst (2007) 2.01
Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial. Lancet Neurol (2012) 1.95
Chemotherapy-induced peripheral neurotoxicity (CIPN): an update. Crit Rev Oncol Hematol (2011) 1.82
Phase II study of pemetrexed plus carboplatin in malignant pleural mesothelioma. J Clin Oncol (2006) 1.66
Erythropoietin both protects from and reverses experimental diabetic neuropathy. Proc Natl Acad Sci U S A (2004) 1.65
Early predictors of oxaliplatin-induced cumulative neuropathy in colorectal cancer patients. J Neurol Neurosurg Psychiatry (2013) 1.55
Effects of manidipine and delapril in hypertensive patients with type 2 diabetes mellitus: the delapril and manidipine for nephroprotection in diabetes (DEMAND) randomized clinical trial. Hypertension (2011) 1.54
Chemotherapy-Induced Peripheral Neurotoxicity assessment: a critical revision of the currently available tools. Eur J Cancer (2010) 1.50
Paclitaxel and Cisplatin-induced neurotoxicity: a protective role of acetyl-L-carnitine. Clin Cancer Res (2003) 1.45
Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention. Neuro Oncol (2012) 1.44
Intraepidermal nerve fiber density in rat foot pad: neuropathologic-neurophysiologic correlation. J Peripher Nerv Syst (2005) 1.37
Randomized multicenter Phase II trial of two different schedules of irinotecan combined with capecitabine as first-line treatment in metastatic colorectal carcinoma. Cancer (2004) 1.31
Comparison of neuropathy-inducing effects of eribulin mesylate, paclitaxel, and ixabepilone in mice. Cancer Res (2011) 1.21
Protective effect of erythropoietin and its carbamylated derivative in experimental Cisplatin peripheral neurotoxicity. Clin Cancer Res (2006) 1.15
Detection of overexpressed and phosphorylated wild-type kit receptor in surgical specimens of small cell lung cancer. Clin Cancer Res (2004) 1.13
Multimodal assessment of painful peripheral neuropathy induced by chronic oxaliplatin-based chemotherapy in mice. Mol Pain (2011) 1.12
Morphological and morphometric analysis of paclitaxel and docetaxel-induced peripheral neuropathy in rats. Eur J Cancer (2005) 1.11
Oxaliplatin-induced neurotoxicity is dependent on the organic cation transporter OCT2. Proc Natl Acad Sci U S A (2013) 1.08
Diabetes-induced myelin abnormalities are associated with an altered lipid pattern: protective effects of LXR activation. J Lipid Res (2011) 1.08
Clinical pattern and associations of oxaliplatin acute neurotoxicity: a prospective study in 170 patients with colorectal cancer. Cancer (2012) 1.08
Interventions for preventing neuropathy caused by cisplatin and related compounds. Cochrane Database Syst Rev (2011) 1.07
Glutamate carboxypeptidase inhibition reduces the severity of chemotherapy-induced peripheral neurotoxicity in rat. Neurotox Res (2009) 1.01
CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats. J Pain Res (2012) 1.00
Chemotherapy-induced neuropathy. Curr Treat Options Neurol (2011) 0.99
Learning disorders in epilepsy. Epilepsia (2006) 0.99
Validation of the Italian version of the Neuropathic Pain Symptom Inventory in peripheral nervous system diseases. Neurol Sci (2009) 0.98
Tubulin: a target for antineoplastic drugs into the cancer cells but also in the peripheral nervous system. Curr Med Chem (2009) 0.98
Role of MAPKs in platinum-induced neuronal apoptosis. Neurotoxicology (2009) 0.97
Chemotherapy-induced peripheral neurotoxicity can be misdiagnosed by the National Cancer Institute Common Toxicity scale. J Peripher Nerv Syst (2011) 0.95
Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats. Eur J Pain (2009) 0.95
Neuroactive steroids and peripheral neuropathy. Brain Res Rev (2007) 0.94
Bortezomib- and thalidomide-induced peripheral neuropathy in multiple myeloma: clinical and molecular analyses of a phase 3 study. Am J Hematol (2014) 0.93
Peripheral neurotoxicity of platinum-based chemotherapy. Nat Rev Cancer (2008) 0.93
Erythropoietin: not just about erythropoiesis. Lancet (2010) 0.90
Informal caregiving burden in advanced non-small cell lung cancer: the HABIT study. J Thorac Oncol (2007) 0.89
Neurotoxicity of platinum compounds: comparison of the effects of cisplatin and oxaliplatin on the human neuroblastoma cell line SH-SY5Y. J Neurooncol (2004) 0.89
Cisplatin-induced peripheral neuropathy: neuroprotection by erythropoietin without affecting tumour growth. Eur J Cancer (2007) 0.89
Glutamate transporters in platelets: EAAT1 decrease in aging and in Alzheimer's disease. Neurobiol Aging (2004) 0.88
NGF protects dorsal root ganglion neurons from oxaliplatin by modulating JNK/Sapk and ERK1/2. Neurosci Lett (2010) 0.88
Paclitaxel toxicity in post-mitotic dorsal root ganglion (DRG) cells. Anticancer Res (2006) 0.88
Effect of the chronic combined administration of cisplatin and paclitaxel in a rat model of peripheral neurotoxicity. Eur J Cancer (2008) 0.88
Mesenchymal stem cells neuronal differentiation ability: a real perspective for nervous system repair? Curr Stem Cell Res Ther (2011) 0.88
Expression and distribution of 'high affinity' glutamate transporters GLT1, GLAST, EAAC1 and of GCPII in the rat peripheral nervous system. J Anat (2008) 0.88
Experimental epothilone B neurotoxicity: results of in vitro and in vivo studies. Neurobiol Dis (2009) 0.87
Role of a pre-existing neuropathy on the course of bortezomib-induced peripheral neurotoxicity. J Peripher Nerv Syst (2008) 0.86
Phase II study of afatinib, an irreversible ErbB family blocker, in EGFR FISH-positive non-small-cell lung cancer. J Thorac Oncol (2015) 0.86
Docetaxel-induced peripheral neuropathy: protective effects of dihydroprogesterone and progesterone in an experimental model. J Peripher Nerv Syst (2009) 0.86
Bortezomib-induced painful peripheral neuropathy: an electrophysiological, behavioral, morphological and mechanistic study in the mouse. PLoS One (2013) 0.86
Bortezomib-induced peripheral neurotoxicity: an update. Arch Toxicol (2014) 0.85
Case report of synchronous multicentric osteosarcoma and review of the literature: the importance of autopsy for diagnosis. Tumori (2005) 0.85
A review of the costs of managing childhood epilepsy. Pharmacoeconomics (2005) 0.85
Activation of the liver X receptor increases neuroactive steroid levels and protects from diabetes-induced peripheral neuropathy. J Neurosci (2010) 0.84
Valproate protective effects on cisplatin-induced peripheral neuropathy: an in vitro and in vivo study. Anticancer Res (2008) 0.84
Comment on: "Is there a role for vitamin D in human reproduction?" Horm Mol Biol Clin Investig (2016) 0.84
Epothilone-induced peripheral neuropathy: a review of current knowledge. J Pain Symptom Manage (2011) 0.83
Diagnostic validity of optic disc and retinal nerve fiber layer evaluations in detecting structural changes after optic neuritis. Ophthalmology (2010) 0.83
Continuous buprenorphine delivery effect in streptozotocine-induced painful diabetic neuropathy in rats. J Pain (2009) 0.83
Bortezomib-induced peripheral neurotoxicity: still far from a painless gain. Haematologica (2007) 0.83
Interventions for preventing neuropathy caused by cisplatin and related compounds. Cochrane Database Syst Rev (2014) 0.82
Different effects of erythropoietin in cisplatin- and docetaxel-induced neurotoxicity: an in vitro study. J Neurosci Res (2010) 0.82
Induction chemotherapy with carboplatin/paclitaxel followed by surgery or standard radiotherapy and concurrent daily low-dose cisplatin for locally advanced non-small cell lung cancer (NSCLC). Am J Clin Oncol (2003) 0.82
Opposite effects of interferon-β on new B and T cell release from production sites in multiple sclerosis patients. J Neuroimmunol (2011) 0.82
Myelin structure is unaltered in chemotherapy-induced peripheral neuropathy. Neurotoxicology (2011) 0.82
Incidence of atypical acute nerve hyperexcitability symptoms in oxaliplatin-treated patients with colorectal cancer. Cancer Chemother Pharmacol (2012) 0.82
Thalidomide chemotherapy-induced peripheral neuropathy: actual status and new perspectives with thalidomide analogues derivatives. Mini Rev Med Chem (2009) 0.81
Focus on the role of Glutamate in the pathology of the peripheral nervous system. CNS Neurol Disord Drug Targets (2008) 0.81
A role for hemopexin in oligodendrocyte differentiation and myelin formation. PLoS One (2011) 0.81
Advanced non-small cell lung cancer management in patients progressing after first-line treatment: results of the cross-sectional phase of the Italian LIFE observational study. J Cancer Res Clin Oncol (2014) 0.81
Chemotherapy-induced peripheral neurotoxicity: how can we improve knowledge? Lancet Oncol (2009) 0.80
TREX1 C-terminal frameshift mutations in the systemic variant of retinal vasculopathy with cerebral leukodystrophy. Neurol Sci (2014) 0.80
Long-term course of oxaliplatin-induced polyneuropathy: a prospective 2-year follow-up study. J Peripher Nerv Syst (2014) 0.79
Neuroactive steroid levels are modified in cerebrospinal fluid and plasma of post-finasteride patients showing persistent sexual side effects and anxious/depressive symptomatology. J Sex Med (2013) 0.79
The fundamental role of morphology in experimental neurotoxicology: the example of chemotherapy-induced peripheral neurotoxicity. Ital J Anat Embryol (2012) 0.79
Treatment of cancer-related anemia with epoetin alfa: a review. Cancer Treat Rev (2004) 0.79
Bone turnover markers and insulin-like growth factor components in metastatic breast cancer: results from a randomised trial of exemestane vs megestrol acetate. Anticancer Res (2003) 0.79
The neuroprotective effect of erythropoietin in docetaxel-induced peripheral neuropathy causes no reduction of antitumor activity in 13762 adenocarcinoma-bearing rats. Neurotox Res (2009) 0.79
An unusual transthyretin gene missense mutation (TTR Phe33Val) linked to familial amyloidotic polyneuropathy. Amyloid (2004) 0.78
Low-dose cisplatin protects human neuroblastoma SH-SY5Y cells from paclitaxel-induced apoptosis. Mol Cancer Ther (2005) 0.78
Actively induced EAE in Lewis rats: characterization of spleen and spinal cord infiltrating lymphocytes by flow cytometry during the course of the disease. J Neuroimmunol (2008) 0.78
A novel AMPK activator reduces glucose uptake and inhibits tumor progression in a mouse xenograft model of colorectal cancer. Invest New Drugs (2014) 0.78
Recent development, applications, and perspectives of mesoporous silica particles in medicine and biotechnology. Curr Med Chem (2009) 0.78
Characterization of and protection from neurotoxicity induced by oxaliplatin, bortezomib and epothilone-B. Anticancer Res (2014) 0.78
Oxaliplatin doublets in non-small cell lung cancer: a literature review. Lung Cancer (2008) 0.78
Pulmonary carcinoid tumours: indolent but not benign. Oncology (2008) 0.78
Novel therapeutic targets in neuropsychiatric disorders: the neuroepigenome. Curr Pharm Des (2014) 0.78